149 related articles for article (PubMed ID: 26725739)
21. Assessing hERG channel inhibition using PatchXpress.
Ly JQ; Shyy G; Misner DL
Clin Lab Med; 2007 Mar; 27(1):201-8. PubMed ID: 17416313
[TBL] [Abstract][Full Text] [Related]
22. Improved throughput of PatchXpress hERG assay using intracellular potassium fluoride.
Zeng H; Penniman JR; Kinose F; Kim D; Trepakova ES; Malik MG; Dech SJ; Balasubramanian B; Salata JJ
Assay Drug Dev Technol; 2008 Apr; 6(2):235-41. PubMed ID: 18471077
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide.
Paul AA; Witchel HJ; Hancox JC
Biochem Biophys Res Commun; 2001 Feb; 280(5):1243-50. PubMed ID: 11162661
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline.
Teschemacher AG; Seward EP; Hancox JC; Witchel HJ
Br J Pharmacol; 1999 Sep; 128(2):479-85. PubMed ID: 10510461
[TBL] [Abstract][Full Text] [Related]
25. Cardiac ion channel safety profiling on the IonWorks Quattro automated patch clamp system.
Cao X; Lee YT; Holmqvist M; Lin Y; Ni Y; Mikhailov D; Zhang H; Hogan C; Zhou L; Lu Q; Digan ME; Urban L; Erdemli G
Assay Drug Dev Technol; 2010 Dec; 8(6):766-80. PubMed ID: 21133679
[TBL] [Abstract][Full Text] [Related]
26. Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG.
Kang J; Chen XL; Wang L; Rampe D
J Pharmacol Exp Ther; 2001 Oct; 299(1):290-6. PubMed ID: 11561091
[TBL] [Abstract][Full Text] [Related]
27. Industrializing electrophysiology: HT automated patch clamp on SyncroPatch® 96 using instant frozen cells.
Polonchuk L
Methods Mol Biol; 2014; 1183():81-92. PubMed ID: 25023303
[TBL] [Abstract][Full Text] [Related]
28. Variability in the measurement of hERG potassium channel inhibition: effects of temperature and stimulus pattern.
Kirsch GE; Trepakova ES; Brimecombe JC; Sidach SS; Erickson HD; Kochan MC; Shyjka LM; Lacerda AE; Brown AM
J Pharmacol Toxicol Methods; 2004; 50(2):93-101. PubMed ID: 15385083
[TBL] [Abstract][Full Text] [Related]
29. Effects of phosphodiesterase (PDE) inhibitors on human ether-a-go-go related gene (hERG) channel activity.
Yunomae K; Ichisaki S; Matsuo J; Nagayama S; Fukuzaki K; Nagata R; Kito G
J Appl Toxicol; 2007; 27(1):78-85. PubMed ID: 17146843
[TBL] [Abstract][Full Text] [Related]
30. A quantitative assessment of hERG liability as a function of lipophilicity.
Waring MJ; Johnstone C
Bioorg Med Chem Lett; 2007 Mar; 17(6):1759-64. PubMed ID: 17239590
[TBL] [Abstract][Full Text] [Related]
31. Manual whole-cell patch-clamping of the HERG cardiac K+ channel.
Chen XL; Kang J; Rampe D
Methods Mol Biol; 2011; 691():151-63. PubMed ID: 20972752
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of rhynchophylline on human ether-a-go-go related gene channel.
Gui L; Li ZW; Du R; Yuan GH; Li W; Ren FX; Li J; Yang JG
Sheng Li Xue Bao; 2005 Oct; 57(5):648-52. PubMed ID: 16220205
[TBL] [Abstract][Full Text] [Related]
33. Flunarizine is a highly potent inhibitor of cardiac hERG potassium current.
Trepakova ES; Dech SJ; Salata JJ
J Cardiovasc Pharmacol; 2006 Feb; 47(2):211-20. PubMed ID: 16495758
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of HERG channels by the local anaesthetic articaine.
Siebrands CC; Friederich P
Eur J Anaesthesiol; 2007 Feb; 24(2):148-53. PubMed ID: 16938156
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of inhibition by olanzapine of cloned hERG potassium channels.
Lee HJ; Choi JS; Hahn SJ
Neurosci Lett; 2015 Nov; 609():97-102. PubMed ID: 26484507
[TBL] [Abstract][Full Text] [Related]
36. Dynamics of hERG closure allow novel insights into hERG blocking by small molecules.
Schmidtke P; Ciantar M; Theret I; Ducrot P
J Chem Inf Model; 2014 Aug; 54(8):2320-33. PubMed ID: 25000969
[TBL] [Abstract][Full Text] [Related]
37. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.
Davie C; Pierre-Valentin J; Pollard C; Standen N; Mitcheson J; Alexander P; Thong B
J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182
[TBL] [Abstract][Full Text] [Related]
38. Channel sialic acids limit hERG channel activity during the ventricular action potential.
Norring SA; Ednie AR; Schwetz TA; Du D; Yang H; Bennett ES
FASEB J; 2013 Feb; 27(2):622-31. PubMed ID: 23139156
[TBL] [Abstract][Full Text] [Related]
39. A place for high-throughput electrophysiology in cardiac safety: screening hERG cell lines and novel compounds with the ion works HTTM system.
Guthrie H; Livingston FS; Gubler U; Garippa R
J Biomol Screen; 2005 Dec; 10(8):832-40. PubMed ID: 16234341
[TBL] [Abstract][Full Text] [Related]
40. Iloperidone (Fanapt®), a novel atypical antipsychotic, is a potent HERG blocker and delays cardiac ventricular repolarization at clinically relevant concentration.
Vigneault P; Pilote S; Patoine D; Simard C; Drolet B
Pharmacol Res; 2012 Jul; 66(1):60-5. PubMed ID: 22465688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
